Lunar's second-quarter sales jump 62%

Article

Lunar is continuing the strong growth trend in revenues it hasbeen experiencing for the last several quarters. The Madison,WI, manufacturer of bone densitometry equipment said that salesfor the second quarter of 1996 (end-December) jumped 62% to

Lunar is continuing the strong growth trend in revenues it hasbeen experiencing for the last several quarters. The Madison,WI, manufacturer of bone densitometry equipment said that salesfor the second quarter of 1996 (end-December) jumped 62% to $16.9million, compared with $10.5 million in the same period last year.

Lunar's growth is primarily due to higher sales of its DPXbone densitometry scanner, especially in the U.S., according topresident Dr. Richard Mazess, who presented the numbers at theHambrecht & Quist Health Care Conference in San Franciscolast week. Sales of Lunar's high-end Expert system also increased,and the company believes it has resolved the component shortagethat has delayed Expert shipments.

Lunar's net income is also strong. The company expects netincome to be at least 24¢ a share after considering the company'srecent three-for-two stock split. That figure includes legal costsof about 3¢ a share related to its settlement of patent litigationwith Hologic (SCAN 10/11/95).

Mazess also announced that Lunar will spin off its Bone CareInternational subsidiary, which conducts early-stage researchon vitamin-D compounds for osteoporosis and other applications.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.